Pasithea Therapeutics Corp. SEC filings KTTA
Pasithea Therapeutics Corp. has 344 filings in SEC EDGAR's recent list, going back to Jan 29, 2021. Its latest annual report, Form ARS, was filed on Aug 7, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 16, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Aug 7, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Jul 24, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 24, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | May 28, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 29, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Oct 26, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | Apr 4, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 30, 2023 | Dec 31, 2022 |
| 10-K/A | Amended annual report | May 12, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Mar 30, 2022 | Dec 31, 2021 |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KTTA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Miami Beach, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1841330
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.